https://www.marshallislandshealthcarebrief.com/article/911844395-radnet-reports-record-first-quarter-financial-results-and-revises-upwards-2026-imaging-center-financial-guidance-ranges-for-revenue-adjusted-ebitda Marshall Islands Healthcare Brief en PressRelease 2026-05-10T20:05:00+00:00 RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow https://ml.globenewswire.com/media/0df5f357-aa64-4998-a83f-f1561aef685d/small/logo-radnet-profile2-jpg.jpg https://www.marshallislandshealthcarebrief.com/article/911806251-healthy-moms-healthy-babies-america-launches-national-campaign-to-cut-u-s-maternal-mortality-in-half-within-five-years Marshall Islands Healthcare Brief en PressRelease 2026-05-10T15:00:00+00:00 Healthy Moms, Healthy Babies America Launches National Campaign to Cut U.S. Maternal Mortality in Half Within Five Years https://ml.globenewswire.com/media/ZDAzNWUwNTYtNjI5ZC00YWZlLWI0ZTctYWVkYzBiYmNlZTQ4LTUwMDE2MjMzOC0yMDI2LTA1LTEwLWVu/tiny/Healthy-Moms-Healthy-Babies-Am.png https://www.marshallislandshealthcarebrief.com/article/911793196-moonlake-immunotherapeutics-announces-positive-outcome-from-its-final-pre-bla-meeting-with-the-u-s-fda-and-reports-first-quarter-2026-financial Marshall Islands Healthcare Brief en PressRelease 2026-05-10T13:00:00+00:00 MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results https://ml-eu.globenewswire.com/media/f894fe8c-bb73-4375-a7de-30c9195f573a/small/moonlake-logo-png.png https://www.marshallislandshealthcarebrief.com/article/911770267-whiteswell-announces-primary-clinical-trial-results-simultaneously-at-heart-failure-2026-congress-and-in-european-journal-of-heart-failure-related-to Marshall Islands Healthcare Brief en PressRelease 2026-05-10T09:09:00+00:00 WhiteSwell Announces Primary Clinical Trial Results Simultaneously at Heart Failure 2026 Congress and in European Journal of Heart Failure related to the DELTA-HF Study in Acute Decompensated Heart Failure https://ml.globenewswire.com/media/f735fa38-d2f5-476c-8e2b-e73cfd79e08e/small/whiteswell-logo-002-png.png https://www.marshallislandshealthcarebrief.com/article/911720880-a-pint-for-kim-blood-drive-breaks-illinois-record-for-the-seventh-year-in-a-row-with-over-650-donations-in-one-day Marshall Islands Healthcare Brief en PressRelease 2026-05-10T00:57:12+00:00 A Pint for Kim Blood Drive Breaks Illinois Record for the Seventh Year in a Row with over 650 Donations in One Day https://ml.globenewswire.com/media/5cbbb955-4170-4c7b-8641-17d04c4e4327/medium/a-pint-for-kim-blood-drive-breaks-illinois-record-for-sevent.jpeg https://www.marshallislandshealthcarebrief.com/article/911623454-carbogen-amcis-nmpa-gmp Marshall Islands Healthcare Brief en PressRelease 2026-05-09T11:28:47+00:00 CARBOGEN AMCIS 上海工厂顺利通过 NMPA GMP 突击检查 https://ml-eu.globenewswire.com/media/92719929-fcdb-45ec-80e1-cc5636960ddc/small/cgam-colour-resized-jpg.jpg https://www.marshallislandshealthcarebrief.com/article/911623475-asuno-launches-sleep-energy-patches-to-address-rising-consumer-demand-for-wellness-solutions Marshall Islands Healthcare Brief en PressRelease 2026-05-09T11:16:33+00:00 Asuno Launches Sleep & Energy Patches to Address Rising Consumer Demand for Wellness Solutions https://ml.globenewswire.com/media/d65e9d1d-b571-4246-86b7-67686ad2eaf7/medium/asuno.jpg https://www.marshallislandshealthcarebrief.com/article/911523470-ispecimen-inc-announces-pricing-of-approximately-2-5-million-private-placement Marshall Islands Healthcare Brief en PressRelease 2026-05-09T01:04:00+00:00 iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement https://ml.globenewswire.com/media/MWMwZjE2YjEtYTE0Yy00NGY4LTljODctMDk0YTk0ZmI5N2E5LTUwMDEzMTIwMy0yMDI2LTA1LTA5LWVu/tiny/iSpecimen-Inc-.png https://www.marshallislandshealthcarebrief.com/article/911523439-open-peer-review-exposes-upv-ethics-committee-s-dilemma-suppress-a-33-year-recognized-breakthrough-or-acknowledge-reviewer-s-ethical-violations-and Marshall Islands Healthcare Brief en PressRelease 2026-05-09T00:24:14+00:00 Open Peer-Review Exposes UPV Ethics Committee’s Dilemma: Suppress a 33 Year Recognized Breakthrough or Acknowledge Reviewer’s Ethical Violations and Remit Final Judgement to the Known Dataset Test to Save Millions of Lives and Billions of Euros https://ml.globenewswire.com/media/40547009-5c5a-4f07-8621-de7e67578439/small/crosetto-foundation-logo-265-pixels-jpg.jpg https://www.marshallislandshealthcarebrief.com/article/911507261-electrocore-to-present-at-the-ld-micro-invitational-xvi-conference-on-may-18-2026 Marshall Islands Healthcare Brief en PressRelease 2026-05-09T00:00:00+00:00 electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.marshallislandshealthcarebrief.com/article/911490631-fda-expands-approval-of-vyvgart-and-vyvgart-hytrulo-to-all-adults-living-with-generalized-myasthenia-gravis Marshall Islands Healthcare Brief en PressRelease 2026-05-08T22:27:12+00:00 FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis https://ml.globenewswire.com/media/YjJmNDYwNjUtMzcyOS00OGUxLTlhZGEtNDU1NmI4YjQxMTE1LTEwOTg0NjYtMjAyNi0wNS0wOC1lbg==/tiny/Muscular-Dystrophy-Association.png https://www.marshallislandshealthcarebrief.com/article/911474186-argenx-announces-u-s-fda-approval-expanding-vyvgart-and-vyvgart-hytrulo-for-use-in-all-adult-patients-living-with-gmg Marshall Islands Healthcare Brief en PressRelease 2026-05-08T21:20:00+00:00 argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.marshallislandshealthcarebrief.com/article/911474620-fda-grants-seventh-approval-under-the-national-priority-voucher-pilot-program Marshall Islands Healthcare Brief en PressRelease 2026-05-08T21:00:59+00:00 FDA Grants Seventh Approval under the National Priority Voucher Pilot Program https://ml.globenewswire.com/media/M2FmNTlkNzctMTZlNi00NzQwLTk2OTctN2NmY2JiYzZhNTExLTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://www.marshallislandshealthcarebrief.com/article/911474308-premier-health-announces-termination-of-forbearance-agreements-with-principal-lenders-and-the-continuance-of-its-strategic-review-process Marshall Islands Healthcare Brief en PressRelease 2026-05-08T21:00:00+00:00 Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process https://ml.globenewswire.com/media/b01bbc61-42f9-4000-9a0a-b1d6719f7396/small/pha-logo-png.png